YKL-40 expression in CD14+ liver cells in acute and chronic injury

被引:20
|
作者
Pizano-Martinez, Oscar [1 ]
Yanez-Sanchez, Irinea [1 ]
Alatorre-Carranza, Pilar [1 ]
Miranda-Diaz, Alejandra [1 ]
Ortiz-Lazareno, Pablo C. [2 ]
Garcia-Iglesias, Trinidad [1 ]
Daneri-Navarro, Adrian [1 ]
Vazquez-Del Mercado, Monica [1 ]
Fafutis-Morris, Mary [1 ]
Delgado-Rizo, Vidal [1 ]
机构
[1] Univ Guadalajara, CUCS, Dept Physiol, Guadalajara 44340, Jalisco, Mexico
[2] Ctr Invest Biomed Occidente IMSS, Div Immunol, Guadalajara 44340, Jalisco, Mexico
关键词
YKL-40; Kupffer cells; Liver cirrhosis; CD14(+) cells; HEPATIC-FIBROSIS; SERUM YKL-40; BETA; TRANSLOCATION; MACROPHAGES; DISEASE;
D O I
10.3748/wjg.v17.i33.3830
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To demonstrate that CD14(+) cells are an important source of the growth factor YKL-40 in acute and chronic liver damage. METHODS: Rats were inoculated with one dose of CCl4 to induce acute damage. Liver biopsies were obtained at 0, 6, 12, 24, 48 and 72 h. For chronic damage, CCl4 was administered three days per week for 6 or 8 wk. Tissue samples were collected, and cellular populations were isolated by liver digestion and purified by cell sorting. YKL-40 mRNA and protein expression were evaluated by real-time polymerase chain reaction and western blot. RESULTS: Acute liver damage induced a rapid increase of YKL-40 mRNA beginning at 12 h. Expression peaked at 24 h, with a 26-fold increase over basal levels. By 72 h however, YKL-40 expression levels had nearly returned to control levels. On the other hand, chronic damage induced a sustained increase in YKL-40 expression, with 7- and 9-fold higher levels at 6 and 8 wk, respectively. The pattern of YKL-40 expression in different subpopulations showed that CD14(+) cells, which include Kupffer cells, are a source of YKL-40 after acute damage at 72 h [0.09 relative expression units (REU)] as well as after chronic injury at 6 wk (0.11 REU). Hepatocytes, in turn, accounted for 0.06 and 0.01 REU after 72 h (acute) or 6 wk (chronic), respectively. The rest of the CD14(-) cells (including T lymphocytes, B lymphocytes, natural killer and natural killer T cells) yielded 0.07 and 0.15 REU at 72 h and 6 wk, respectively. YKL-40 protein expression in liver was detected at 72 h as well as 6 and 8 wk, with the highest expression relative to controls (11-fold; P <= 0.05) seen at 6 wk. Macrophages were stimulated by lipopolysaccharide. We demonstrate that under these conditions, these cells showed maximum expression of YKL-40 at 12 h, with P < 0.05 compared with controls. CONCLUSION: Hepatic CD14(+) cells are an YKL-40 mRNA and protein source in acute and chronic liver injury, with expression patterns similar to growth factors implicated in inflammation-fibrogenesis. (C) 2011 Baishideng. All rights reserved.
引用
收藏
页码:3830 / 3835
页数:6
相关论文
共 50 条
  • [1] YKL40 expression in CD14~+ liver cells in acute and chronic injury
    Oscar Pizano-Martínez
    Irinea Yaez-Sánchez
    Pilar Alatorre-Carranza
    Alejandra Miranda-Díaz
    Pablo C Ortiz-Lazareno
    Trinidad García-Iglesias
    Adrian Daneri-Navarro
    Mónica Vázquez-Del Mercado
    Mary Fafutis-Morris
    Vidal Delgado-Rizo
    World Journal of Gastroenterology, 2011, 17 (33) : 3830 - 3835
  • [2] YKL-40 Expression in Traumatic Brain Injury: An Initial Analysis
    Bonneh-Barkay, Dafna
    Zagadailov, Pavel
    Zou, Huichao
    Niyonkuru, Christian
    Figley, Matthew
    Starkey, Adam
    Wang, Guoji
    Bissel, Stephanie J.
    Wiley, Clayton A.
    Wagner, Amy K.
    JOURNAL OF NEUROTRAUMA, 2010, 27 (07) : 1215 - 1223
  • [3] YKL-40 and inflammatory genes expression in chronic ischemic myocardium
    Wang, Y.
    Gabrielsen, A.
    Ripa, R.
    Jorgensen, E.
    Kastrup, J.
    CARDIOVASCULAR RESEARCH, 2010, 87 : S57 - S57
  • [4] Serum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cells
    Mylin, Anne K.
    Rasmussen, Thomas
    Johansen, Julia S.
    Knudsen, Lene M.
    Norgaard, Peter H.
    Lenhoff, Stig
    Dahl, Inger M. S.
    Johnsen, Hans E.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 77 (05) : 416 - 424
  • [5] YKL-40 EXPRESSION IN INTRACRANIAL MENINGIOMAS
    Okada, M.
    Ogawa, D.
    Wei, Z.
    Ookubo, S.
    Miyake, K.
    Kawai, N.
    Tamiya, T.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1132 - 1132
  • [6] YKL-40 expression in breast cancer
    Roslind, A
    Johansen, JS
    Junker, N
    Nielsen, DL
    Bentzon, N
    Price, PA
    Balslev, E
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 877S - 877S
  • [7] YKL-40 expression in neuroinflammatory conditions
    Dafna, Bonneh-Barkay
    Guoji, Wang
    Adam, Starkey
    Ronald, Hamilton
    Zou Huichao
    Stephanie, Bissel
    Amy, Wagner
    Clayton, Wiley
    JOURNAL OF NEUROIMMUNOLOGY, 2010, 228 (1-2) : 88 - 88
  • [8] YKL-40 expression in chronic obstructive pulmonary disease: relation to acute exacerbations and airway remodeling
    Lai, Tianwen
    Wu, Dong
    Chen, Min
    Cao, Chao
    Jing, Zhiliang
    Huang, Li
    Lv, Yingying
    Zhao, Xuanna
    Lv, Quanchao
    Wang, Yajun
    Li, Dongming
    Wu, Bin
    Shen, Huahao
    RESPIRATORY RESEARCH, 2016, 17
  • [9] YKL-40 expression in chronic obstructive pulmonary disease: relation to acute exacerbations and airway remodeling
    Tianwen Lai
    Dong Wu
    Min Chen
    Chao Cao
    Zhiliang Jing
    Li Huang
    Yingying Lv
    Xuanna Zhao
    Quanchao Lv
    Yajun Wang
    Dongming Li
    Bin Wu
    Huahao Shen
    Respiratory Research, 17
  • [10] The significance of YKL-40 protein in liver fibrosis
    Tao, Hui
    Yang, Jing-Jing
    Shi, Kai-Hu
    Huang, Cheng
    Zhang, Lei
    Lv, Xiong-Wen
    Li, Jun
    INFLAMMATION RESEARCH, 2014, 63 (04) : 249 - 254